Abstract: Cytokines and high mobility group box chromosomal protein-1 (HMGB-1) play key roles in inflammatory conditions. While hemofiltration has been shown to remove cytokines, removal of cytokines and HMGB-1 by hemofiltration using a polyethersulfone membrane has not been reported. This study aimed to test the hypothesis that the polyethersulfone membrane will achieve higher removal performance for substances including inflammatory cytokines compared to other hemofilters, while retaining low albumin removal capacity. Subjects were eight healthy volunteers. We collected 400 mL each of blood samples into containers with heparin and added 30 mg of lipopolysaccharide to spike cytokines and HMGB-1. After incubation at 39ºC for 12 h, each blood sample was circulated through a hemofiltration circuit with a polyethersulfone hemofilter (2.1 m 2 or 1.1 m 2 ) at a filtration flow rate of 2 L/h. Measurement samples were collected from arterial, venous, and ultrafiltrate sampling points. Concentrations of cytokines (IL-1ß, IL-4, IL-6, IL-8, IL-10, and tumor necrosis factor [TNF-a]), HMGB-1, and albumin were determined at each time point (1, 4, 8, 12, and 24h). High sieving coefficients (SCs) above 0.8 were obtained for all cytokines except for TNF-a as well as HMGB-1, whereas the SC for albumin was less than 0.04 with both hemofilters. The hemofilter with a larger membrane area achieved significantly higher clearances for TNF-a and HMGB-1, and slower decreases in SCs over time for IL-1ß, IL-6, IL-8, TNF-a, and albumin. Continuous hemofiltration with a polyethersulfone membrane achieved high efficiency removal of cytokines and HMGB-1, without excessive removal of albumin.
The release of various inflammatory and antiinflammatory cytokines is accelerated under conditions that cause systemic inflammatory reactions, such as sepsis and multiple traumas, and plays an important role in the formation of pathological conditions (1, 2) . In addition, the involvement of high mobility group box chromosomal protein-1 (HMGB-1), a substance originally identified as an endogenous DNA binding protein (3) , in various inflammatory pathologies has been revealed, with the elucidation of the clinical condition of sepsis and the mechanism of RAGE-mediated cellular activation (4) . The excess release of humoral mediators such as cytokines and HMGB-1 can itself cause organ dysfunction and is sometimes fatal (5, 6) . Therefore, the elimination of cytokines and HMGB-1 is expected to improve the disease state, and various methods have been devised to this end. So far, however, methods for removing specific substances using antibodies against various cytokines have not proven to be particularly beneficial (7) (8) (9) (10) . On the other hand, a recent study reported that blood purification therapy for sepsis improved survival and hemodynamics, and as the mechanism, nonspecific removal of harmful substances including cytokines appeared to be effective (11, 12) . Many humoral mediators such as cytokines and HMGB-1 are middle molecules in the range of 0.5 to 60 kDa. Various studies have shown that these molecules can be removed by blood purification therapy (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . In a previous study, we also demonstrated that various humoral mediators could be removed by hemofiltration with a cellulose triacetate (CTA) membrane, using a blood purification model created with human blood (17) .
Among the various cytokine removal techniques, however, the optimal method and device have not yet been identified. In a systematic review of ex vivo data relating to extracorporeal cytokine removal techniques, hemofiltration using a high cutoff hemofilter with increased membrane pore size was found to be the most efficient method for cytokine removal (16, 22, 23) . On the other hand, several studies have examined the utility of high cut-off hemofilters as a cytokine removal device, and reported that those with high cytokine removal efficiency also show high albumin removal efficiency (18, 21) .
In Japan, a new designed high cut-off filter using polyethersulfone (PES) as a membrane material was developed and has recently become available for clinical use as a hemofilter for continuous renal replacement therapy (CRRT) including continuous hemofiltration (CHF), hemodialysis (CHD) and hemodiafiltration (CHDF). Unlike conventional PES membranes, this membrane has a dual structure consisting of a thin dense layer and thick supportive layer, and can clearly separate substances due to the homogenized pore size of the dense layer (25) . However, to date, no report has examined the extent of its capacity to remove various cytokines and HMGB-1. Therefore, we conducted an ex vivo study using human blood to test the hypothesis that this high cut-off filter will achieve higher removal performance for substances including inflammatory cytokines compared to other hemofilters, while retaining low albumin removal capacity.
MATERIALS AND METHODS

Blood collection and cytokine induction
This study was approved by the ethics committee of our facility. After obtaining written informed consent from eight healthy volunteers, a 400-mL blood sample was collected from each participant. At the time of blood sampling, it was confirmed that none of the participants had a history of fever or infection, or used nonsteroidal anti-inflammatory drugs ≥1 week prior to study participation. Blood samples (400 mL each) were heparinized, and 30 mg of lipopolysaccharide (Escherichia coli serotype O127: B8; Sigma Aldrich, St. Louis, MO, USA) was added. After 12 h of incubation at 39 C in a water bath, each sample was divided into halves and mixed with 200 mL physiological saline to prepare two 400-mL blood reservoirs.
Hemofilters and hemofiltration circuits
Hemofiltration circuits were prepared by placing either a 2.1-m 2 or 1.1-m 2 PES membrane hemofilter (PUT-21 eco or PUT-11 eco; Nipro, Osaka, Japan) and filling with cytokine-induced blood. Figure 1 shows the hemofiltration circuit set-up prepared according to a report by Yasuda et al. (17) . Hemofiltration was performed at a blood flow rate of 150 mL/min and filtration flow rate of 2.0 L/h for 24 h. The filtrate was returned to the blood reservoir and allowed to recirculate within the circuit. The two hemofiltration circuits were started at the same time, and measurement samples (2 mL) were collected from arterial, venous, and ultrafiltrate sampling points at 1, 4, 8, 12 , and 24 h. Analyses were performed singly. Collected blood samples were centrifuged at 10 000 rpm for 10 min, and the supernatant was stored frozen at −80 C after dividing into three aliquots of 200 μL each for the measurement of cytokines, HMGB-1, and albumin. Laboratories, Hercules, CA, USA). HMGB-1 was measured using enzyme-linked immunosorbent assay (ELISA) (Shino-Test, Tokyo, Japan). Plasma albumin levels were measured with a multichannel biochemical analyzer, and filtrate albumin levels were measured by immunoturbidimetry.
Calculation
The sieving coefficient (SC), clearance (CL), and adsorption (Ads) were calculated using the following equations, as reported previously (17):
where Ci and Co are the supernatant concentrations (pg/mL) on the filter inlet side and filter outlet side, respectively, Cuf is the filtrate concentration (pg/mL), Qbi is the blood flow rate on the filter inlet side, Quf is the ultrafiltration flow rate (mL/min) on the filter inlet side, and Qpli and Qplo are the plasma flow rates on the filter inlet side and filter outlet side, respectively. Mean CLs were calculated from the approximate curve created by plotting the concentration data.
Statistical analysis
Results are expressed as median and interquartile ranges. The Wilcoxon signed-rank test was used for comparisons of SCs and CLs between the two membranes. Friedman's test was used to analyze changes over time, and the Wilcoxon signed-rank test with Bonferroni correction was used as a post hoc test. All statistical analyses were performed using Statflex Statistical Software version 6.0 (Artech Co., Ltd., Osaka, Japan). P < 0.05 was considered statistically significant. Table 1 shows the changes in concentrations for cytokines, HMGB-1, albumin, and hematocrit. Cytokines and HMGB-1 decreased and hematocrit and albumin increased with time. Table 2 shows mean CLs over the 24-h period by membrane type. Mean CLs for IL-6, TNF-α, HMGB-1, and albumin were significantly higher with the 2.1-m 2 hemofilter than with the 1.1-m 2 hemofilter. No cytokine adsorption was observed for all substances.
RESULTS
Cytokine concentrations and mean clearances
Changes in SC over time
High SCs above 0.8 were obtained for all cytokines except for TNF-α as well as HMGB-1, whereas the SC for albumin was less than 0.04 with both 2.1-m 2 and 1.1-m 2 hemofilters (Fig. 2 ). Significant decreases in SCs were observed over time for IL-1β, IL-6, IL-8, TNF-α, and albumin with both hemofilters. For IL-1β, IL-10, and albumin, SCs were significantly higher with the 2.1-m 2 hemofilter than with the 1.1-m 2 hemofilter beginning at 8 h after the initiation of CHF and thereafter. For TNF-α and HMGB-1, significant differences in SCs were observed between the two hemofilters from the early stages.
DISCUSSION
The present study provided two important findings. First, CHF using a PES membrane hemofilter achieved high SCs for both cytokines and HMGB-1, while the SC for albumin remained low at <0.04. Second, the assessment of the effect of different membrane areas revealed that mean CLs for IL-6, HMGB-1, TNF-α, and albumin were significantly higher with the 2.1-m 2 hemofilter than with the 1.1-m 2 hemofilter, and moreover, the former showed slower decreases in SCs over time for some substances.
First, CHF using a PES membrane hemofilter achieved high SCs for both cytokines and HMGB-1, while the SC for albumin remained low at <0.04. Table 3 shows the comparison of SCs between the present study data and other membrane data (13) (14) (15) 17, 18, 20, 24) . In this study, SCs for IL-6, TNF-α, and albumin were 0.92, 0.85, and 0. (18) . On the other hand, the hemofilter also had a high SC for albumin (0.513), which is roughly 15-fold the value obtained in the present study. Uchino et al. used a high cut-off polyamide filter at a filtration flow rate of 1 L/h and achieved SCs of 0.73 for IL-6 and 0.31 for TNF-α (13) . While these values are lower than the SCs obtained in the present study, the SC for albumin, 0.06, is comparable to our result. However, to the best of our knowledge, no study has reported a hemofilter that could achieve high SCs for all cytokines examined in the present study, while retaining an SC of <0.04 for albumin (13) (14) (15) (16) (17) (18) 20, 21, 24) . Few studies have investigated the removal of HMGB-1 by CRRT. Previously, we used a CTA membrane filter in the same experimental system as in the present study, and obtained an SC of 0.1 for HMGB-1 (17) ; therefore, the present study shows that the PES membrane filter achieves higher HMGB-1 removal efficiency.
Second, the assessment of the effect of different membrane areas revealed that mean CLs for IL-6, HMGB-1, TNF-α, and albumin were significantly higher with the 2.1-m 2 hemofilter than with the 1.1-m 2 hemofilter, and moreover, the former showed slower decreases in SCs over time for some substances. The larger the membrane area, the higher the number of pores that permeate substances, and so the substance removal efficiency is also expected to increase. Messer et al. compared membranes having an area of 2.0 vs. 0.4 m 2 and reported that clearance for middle molecules was higher with the former (19) . We also obtained better CLs when using the filter with a larger membrane area. The molecular weight of IL-6 and HMGB-1 are relatively high (28 and 30 kDa), and the actual molecular weight of TNF-α, which forms a trimer in blood, is supposedly 52.5 kDa. Thus, these substances are considered difficult to remove by hemofiltration (15) . Presumably, the results of the present study could be explained by the greater impact of the increased membrane area on higher molecular weight substances, which are generally difficult to remove. In general, SCs tend to decrease gradually over time, as blood cells and protein components foul the pores of the hemofilter in CHF. Therefore, with larger membrane area, the impact of fouling might become less significant, as the number of pores is increased. While the SC decreases with increasing filtration flow, the absolute value of CL increases (13) . In the present study, it can be presumed that CLs could be increased by increasing the filtration rate. However, an effluent flow rate of 20-25 mL/kg/h is considered appropriate in patients with acute kidney injury (26) , and in the actual clinical setting, CHF is likely to be performed at roughly 2 L/h in many cases. Ronco et al. advocated the "peak concentration hypothesis," (12) that is, the idea that immunological homeostasis can be improved by eliminating over-produced humoral mediators and decreasing their blood concentrations below certain thresholds. On the other hand, highflow-rate continuous blood purification therapy aimed at removing harmful substances, such as cytokines, has been shown to be of no benefit in multiple randomized controlled trials, possibly due to excessive removal of essential substances (27) (28) (29) . The use of the hemofilter examined in the present study, which is highly efficient in its ability to remove cytokines, is expected to allow for suppression of peak cytokine concentrations at a lower hemofiltration flow rate compared to conventional hemofilters. This could help prevent excessive removal of essential small molecules, such as amino acids and electrolytes, as well as therapeutic agents (e.g., antibiotics for sepsis treatment).
There are some limitations to this study. First, although we used human blood, the ex vivo study design did not allow us to adequately address actual clinical symptoms. Atan et al. performed CHF using a high cut-off membrane and reported that, despite its high cytokine removal efficiency, it did not decrease blood concentrations of cytokines (20) . However, the PES membrane examined in the present study is considered to have the highest cytokine removal efficiency among all existing hemofilters, and thus, further investigation is warranted to verify its effectiveness in the actual clinical situation. Second, the filtration flow rate was limited to 2 L/h. As mentioned above, the present study focused only on the flow rate that is considered closest to actual clinical situations. Given the unprecedentedly high efficiency of the PES membrane hemofilter, the optimal hemofiltration rate in the actual clinical setting needs to be verified. Third, we did not perform a morphological assessment in the present study. The PES membrane has a two-layer structure consisting of a thin dense layer and a coarse support layer, and it is expected that the pore size becomes more uniform as the dense layer gets thinner. This suggests that the membrane may exhibit clear fractionation characteristics, but the present study did not morphologically demonstrate these characteristics. Moreover, adhesion of blood cells and proteins, which is presumed to be the cause of a decrease in SCs over time, was not visualized. Therefore, in addition to the present biochemical assessment, a morphological assessment using an electron microscope will be needed in the future. Fourth, intra-circuit pressure including transmembrane pressure was not measured in this study. It is necessary to investigate the correlation with transmembrane pressure and transport of substances in order to evaluate the mechanism of transmembrane transport. Fifth, we diluted the blood samples with saline prior to the experiment in order to fill two circuits at the same time. So, concentrations of albumin and hematocrit in the experimental blood samples were lower than normal blood. As albumin concentration and hematocrit are the factors that affect the fouling, it is possible that modified the changes of SCs and CLs. IL, interleukin; Qbi, blood flow rate on the filter inlet side; Quf, ultrafiltration flow rate; TNF-α, tumor necrosis factor-α.
